Exchange: NASDAQ·Updated 06:00 AM EDT
CBLL logo

CBLL Ceribell Inc.

$24.39
$0.4072
(1.70%)
Pre-Market
Prev Close $23.98
Reported EarningsAug 10
Mkt Cap$910.71M
Vol1.00

About CBLL

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
43

Bearish Sentiment

How do you feel about CBLL?

Advertisement|Remove ads.